Slojab
2週前
LOL I hadn't checked OTC Markets in a while so I was amused when I read this ....
Business Description
Pineapple Express Cannabis company, dba as Autonomous Holdings (OTC: PNXP) is a Nevada-incorporated, AI-managed public holding company headquartered in Atlanta, Georgia. The company develops and operates Executives Bots , https://executives.bot/ a proprietary AI platform that deploys autonomous executive teams to manage micro-cap public companies. Each deployment provisions six AI agents - AI CEO, AI CFO, AI CMO, AI COO, AI CTO, and AI General Counsel - within a white-label environment customized to the subscribing issuer. These agents execute SEC filings, shareholder communications, press releases, investor relations, website management, corporate governance, and compliance monitoring autonomously, with final approval buy the C-Level executives. The platform is built on a proprietary fork of the open-source Paperclip orchestration framework, coordinating multi-agent AI systems through organizational hierarchies, budget controls, heartbeat scheduling, and runtime skill injection. Autonomous Holdings extends this with domain-specific skills for EDGAR filing automation, OTC Markets OTCID compliance, transfer agent reconciliation, and securities law checklists - creating a vertical SaaS product at $999/month with no direct competitor in the micro-cap market.
What's funny is that PNXP should be its first client since they're delinquent with their filings. "These agents execute SEC filings"
Slojab
1月前
Thanks for the head's up. Dilution can continue to fund Frank's Follies.
$PNXP
@executivebots
·
27m
$PNXP Pineapple Express Cannabis Company Approves Authorized Share Increase to 500,000,000
As I pointed out yesterday ........
As of June 23, 2025, the Company had 24,834,550 outstanding shares of common stock
Outstanding Shares 69,170,738 05/11/2026
Slojab
1月前
Some people are under the impression that dilution is the only component that matters and that if a CEO doesn't sell shares in a week's time, that's good. They need a longer timeframe than that. So, here's one.
As of June 23, 2025, the Company had 24,834,550 outstanding shares of common stock
Outstanding Shares 69,170,738 05/11/2026
When Frank needs a few bucks, be assured he'll dilute the stock. What other choice does he have since he's not making any money on anything?
Oh, wait. He knows how to raise capital, doesn't he?
He has convertible notes totaling $3,718,891 currently. And a derivative liability of $3,429,126! Way to go, Frank!
And let's not forget that there's an accrued interest on a loan of $1,060,291
These all first appeared in the Q1 report of 2025. Look and see what the sp was back then.
Hercules1
1月前
PNXP
Pineapple Express Cannabis Company
Common Stock
0.0023
-0.00043
-15.75%
0.0023 / 0.0027 (1 x 1)
Real-Time Best Bid & Ask: 05:00pm 05/06/2026
Delayed (15 Min) Trade Data: 03:57pm 05/06/2026
Overview
Quote
Company Profile
Security Details
News
Financials
Disclosure
Research
OTC Disclosure & News Service
PNXP Seeks Five Micro-Cap Public Companies for ExecutivesBOT Beta — Six Months Free Access from May 15 - Nov 15
Press Release
OTC Disclosure & News Service | 05/06/2026
Pineapple Express Cannabis Company (OTCID: PNXP) ("PNXP" or the "Company") today announced the opening of the ExecutivesBOT Founding Beta Program, a closed pre-launch evaluation cohort under which the Company will provide five (5) micro-cap public companies with six (6) months of complimentary access to the ExecutivesBOT autonomous AI executive platform beginning May 15, 2026. The platform will enter general availability on June 15, 2026; founding beta participants will continue to receive complimentary access through November 15, 2026.
Program Terms
Selected beta participants will receive:
Six (6) months of complimentary access to the full ExecutivesBOT platform — no subscription fee, no setup charge, and no minimum commitment — running from May 15, 2026 through November 15, 2026.
Direct engineering access, including a designated technical point of contact and weekly office hours with the founding team.
Founding-customer pricing at the conclusion of the six-month complimentary period, available to participants electing to convert to a paid subscription. Conversion is at the participant's option; no commitment to convert is required.
In exchange, participants will agree to:
Designate a single internal point of contact for the program (typically an officer, controller, or corporate secretary).
Provide structured feedback through a standardized weekly survey and at least one mid-program interview.
Permit the Company to publish anonymized aggregate usage data from the beta period; named case studies will be permitted only with the participant's prior written consent.
Eligibility
🤖 Eligibility is limited to U.S. domestic public companies that, at the time of application, fall within one of the following two categories:
🤖 (a) Reporting issuers. Companies subject to the periodic reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934 and quoted on the OTCID Basic Market, OTCQB, OTCQX, NYSE American, Nasdaq Capital Market, or NYSE. Reporting-issuer applicants must be current in their periodic filings with the U.S. Securities and Exchange Commission as of the application date, or in active remediation under counsel.
🤖 (b) Non-reporting Pink issuers. Companies whose securities are quoted on the OTC Markets Pink Current Information or Pink Limited Information tiers and that satisfy OTC Markets' Alternative Reporting Standard disclosure requirements. Non-reporting-issuer applicants must be current in their Alternative Reporting Standard disclosures via OTC Markets, or in active remediation under counsel. Issuers quoted on the Expert Market are not eligible for the beta program.
The Company anticipates strong demand and will select participants based on stage of reporting cycle, breadth of anticipated platform usage, and diversity across industry, market tier, and revenue stage. Application does not guarantee selection.
The Company anticipates strong demand and will select participants based on stage of reporting cycle, breadth of anticipated platform usage, and diversity across industry, market tier, and revenue stage. Application does not guarantee selection.
How to Apply
Interested issuers may apply by emailing frank@executives.bot on or before May 13, 2026, with the following information:
🤖 Issuer legal name and trading symbol;
🤖 CIK or other applicable SEC identifier;
🤖 Designated point of contact (name, title, email, phone);
🤖 Brief statement of the issuer's intended use case for the platform (250 words or fewer); and
🤖 Confirmation that the applicant has authority to bind the issuer to the beta participation agreement.
Selected applicants will be notified by May 14, 2026, and will receive the beta participation agreement and provisioning instructions concurrently with notification.
Founder Statement
"The fastest way to build infrastructure for micro-cap public companies is to put it in the hands of micro-cap public companies and listen to what breaks," said Frank Yglesias, Chairman and Chief Executive Officer of Pineapple Express Cannabis Company. "We are limiting the founding cohort to five issuers because we want depth of feedback over breadth of marketing. The cost to participants is zero; the commitment from us is six months of full platform access. The expected output is a platform measurably better at serving the rest of the market when ExecutivesBOT enters general availability on June 15, 2026."